{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T15:10:07Z","timestamp":1751728207273,"version":"3.41.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,5]]},"DOI":"10.7759\/cureus.87330","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T14:29:11Z","timestamp":1751725751000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Aggressive Hepatocellular Carcinoma Presenting With Chest Wall Metastasis and Portal Vein Thrombosis: A Rare Case and a Multidisciplinary Perspective"],"prefix":"10.7759","author":[{"given":"Nasim","family":"Salimiaghdam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene O","family":"Pokuaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet JM","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al.. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021, 7:6. 10.1038\/s41572-020-00240-3","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee QM","year":"2019","unstructured":"Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019, 16:411-28. 10.1038\/s41575-019-0145-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000539371","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"17","author":"Tacke F","year":"2024","unstructured":"Tacke F, Horn P, Wong VWS, et al.. EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts. 2024, 17:374-444. 10.1159\/000539371","journal-title":"Obes Facts"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.08.030","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","volume":"68","author":"Ioannou GN","year":"2017","unstructured":"Ioannou GN, Green PK, Berry K. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma. J Hepatol. 2017, 68:25-32. 10.1016\/j.jhep.2017.08.030","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-007-0154-7","article-title":"Prognosis and results after resection of hepatocellular carcinoma with macroscopic vascular invasion","volume":"11","author":"Shah SA","year":"2007","unstructured":"Shah SA, Wei AC, Cleary SP, et al.. Prognosis and results after resection of hepatocellular carcinoma with macroscopic vascular invasion. J Gastrointest Surg. 2007, 11:589-95. 10.1007\/s11605-007-0154-7","journal-title":"J Gastrointest Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.6402","article-title":"Extrahepatic spread of hepatocellular carcinoma: spectrum of imaging findings","volume":"197","author":"Sneag DB","year":"2011","unstructured":"Sneag DB, Krajewski K, Giardino A, O'Regan KN, Shinagare AB, Jagannathan JP, Ramaiya N. Extrahepatic spread of hepatocellular carcinoma: spectrum of imaging findings. AJR Am J Roentgenol. 2011, 197:W658-64. 10.2214\/AJR.10.6402","journal-title":"AJR Am J Roentgenol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2005.03919.x","article-title":"Clinical features of hepatocellular carcinoma with extrahepatic metastases","volume":"20","author":"Natsuizaka M","year":"2005","unstructured":"Natsuizaka M, Omura T, Akaike T, et al.. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol. 2005, 20:1781-7. 10.1111\/j.1440-1746.2005.03919.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.036673","article-title":"Dual-tracer PET\/CT imaging in evaluation of metastatic hepatocellular carcinoma","volume":"48","author":"Ho CL","year":"2007","unstructured":"Ho CL, Chen S, Yeung DW, Cheng TK. Dual-tracer PET\/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med. 2007, 48:902-9. 10.2967\/jnumed.106.036673","journal-title":"J Nucl Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i13.2139","article-title":"Chest wall metastasis from unknown primary site of hepatocellular carcinoma","volume":"12","author":"Hyun YS","year":"2006","unstructured":"Hyun YS, Choi HS, Bae JH, et al.. Chest wall metastasis from unknown primary site of hepatocellular carcinoma. World J Gastroenterol. 2006, 12:2139-42. 10.3748\/wjg.v12.i13.2139","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1186\/s43055-021-00612-z","article-title":"Hepatocellular carcinoma with uncommon sites of metastasis: a rare case report","volume":"52","author":"Targe M","year":"2021","unstructured":"Targe M, Yasam VR, Nagarkar R, et al.. Hepatocellular carcinoma with uncommon sites of metastasis: a rare case report. Egypt J Radiol Nucl Med. 2021, 52:228.","journal-title":"Egypt J Radiol Nucl Med"},{"key":"ref12","article-title":"Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west","volume":"4","author":"Lu J","year":"2019","unstructured":"Lu J, Zhang XP, Zhong BY, et al.. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west. Lancet Gastroenterol Hepatol. 2019, 4:721-30.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221104797","article-title":"The efficacy and safety of anticoagulants in the treatment of cirrhotic portal vein thrombosis: a systematic review and meta-analysis","volume":"28","author":"Zhang Z","year":"2022","unstructured":"Zhang Z, Zhao Y, Han B, Zhu Z, Sun L, Cui X. The efficacy and safety of anticoagulants in the treatment of cirrhotic portal vein thrombosis: a systematic review and meta-analysis. Clin Appl Thromb Hemost. 2022, 28:4797. 10.1177\/10760296221104797","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn RS","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, et al.. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020, 382:1894-905. 10.1056\/NEJMoa1915745","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: a randomized phase 3 non-inferiority trial","volume":"391","author":"Kudo M","year":"2018","unstructured":"Kudo M, Finn RS, Qin S, et al.. Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: a randomized phase 3 non-inferiority trial. Lancet. 2018, 391:1163-73. 10.1016\/S0140-6736(18)30207-1","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in patients with advanced and progressing hepatocellular carcinoma","volume":"379","author":"Abou-Alfa GK","year":"2018","unstructured":"Abou-Alfa GK, Meyer T, Cheng AL, et al.. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma. N Engl J Med. 2018, 379:54-63. 10.1056\/NEJMoa1717002","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S175703","article-title":"The role of external beam radiotherapy for hepatocellular carcinoma patients with lymph node metastasis: a meta-analysis of observational studies","volume":"10","author":"Rim CH","year":"2018","unstructured":"Rim CH, Kim CY, Yang DS, Yoon WS. The role of external beam radiotherapy for hepatocellular carcinoma patients with lymph node metastasis: a meta-analysis of observational studies. Cancer Manag Res. 2018, 10:3305-15. 10.2147\/CMAR.S175703","journal-title":"Cancer Manag Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.103990","article-title":"The management of oligometastatic disease in colorectal cancer: present strategies and future perspectives","volume":"186","author":"Carconi C","year":"2023","unstructured":"Carconi C, Cerreti M, Roberto M, et al.. The management of oligometastatic disease in colorectal cancer: present strategies and future perspectives. Crit Rev Oncol Hematol. 2023, 186:103990. 10.1016\/j.critrevonc.2023.103990","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4786-7","article-title":"Infiltrative hepatocellular carcinoma: natural history and comparison with multifocal, nodular hepatocellular carcinoma","volume":"22","author":"Yopp AC","year":"2015","unstructured":"Yopp AC, Mokdad A, Zhu H, Mansour JC, Balch GC, Choti MA, Singal AG. Infiltrative hepatocellular carcinoma: natural history and comparison with multifocal, nodular hepatocellular carcinoma. Ann Surg Oncol. 2015, 22:1075-82. 10.1245\/s10434-015-4786-7","journal-title":"Ann Surg Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2021\/47185.14451","article-title":"Role of MRI in evaluation of focal liver lesions: a cross-sectional study","volume":"15","author":"Kotnis SM","year":"2021","unstructured":"Kotnis SM, NagaraJ RH, Brahma PJ. Role of MRI in evaluation of focal liver lesions: a cross-sectional study. J Clin Diagn Res. 2021, 15:7-20. 10.7860\/JCDR\/2021\/47185.14451","journal-title":"J Clin Diagn Res"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.3381","article-title":"The current landscape of immune checkpoint blockade in hepatocellular carcinoma: a review","volume":"7","author":"Pinter M","year":"2021","unstructured":"Pinter M, Jain RK, Duda DG. The current landscape of immune checkpoint blockade in hepatocellular carcinoma: a review. JAMA Oncol. 2021, 7:113-23.","journal-title":"JAMA Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/378769-recurrent-aggressive-hepatocellular-carcinoma-presenting-with-chest-wall-metastasis-and-portal-vein-thrombosis-a-rare-case-and-a-multidisciplinary-perspective","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T14:29:12Z","timestamp":1751725752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/378769-recurrent-aggressive-hepatocellular-carcinoma-presenting-with-chest-wall-metastasis-and-portal-vein-thrombosis-a-rare-case-and-a-multidisciplinary-perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.87330","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,5]]}}}